BORTEZOMIB INDUCES APOPTOSIS IN BOTH RESTING AND CD40-ACTIVATED CLL B CELLS

被引：0
|
作者：
Simeone, L. [1 ]
Chiurazzi, F. [1 ]
Avilia, S. [1 ]
Romano, C. [1 ]
Sellitto, A. [1 ]
De Fanis, U. [1 ]
Lucivero, G. [1 ]
Rotoli, B. [1 ]
机构：
[1] Federico II Univ Naples, Dept Biochem & Med Biotechnol, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P136
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] FAS LIGATION INDUCES APOPTOSIS OF CD40-ACTIVATED HUMAN B-LYMPHOCYTES
    GARRONE, P
    NEIDHARDT, EM
    GARCIA, E
    GALIBERT, L
    VANKOOTEN, C
    BANCHEREAU, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05): : 1265 - 1273
  • [2] CD40-activated B cells contribute to mesothelioma tumor regression
    Jackaman, Connie
    Cornwall, Scott
    Graham, Peter Thomas
    Nelson, Delia Jane
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (02): : 255 - 267
  • [3] Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes
    Dubois, B
    Vanbervliet, B
    Fayette, J
    Massacrier, C
    VanKooten, C
    Briere, F
    Banchereau, J
    Caux, C
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05): : 941 - 951
  • [4] Inflammation enhances the vaccination potential of CD40-activated B cells in mice
    Mathieu, Melissa
    Odagiu, Livia
    Gaudot, Lea
    Daudelin, Jean-Francois
    Melichar, Heather J.
    Lapointe, Rejean
    Labrecque, Nathalie
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (02) : 269 - 279
  • [5] Resistance to Fas-induced apoptosis in CD40-activated B-chronic lymphocytic leukemia cells.
    NeidhardtBerard, EM
    Garcia, E
    Durand, I
    Coiffier, B
    Salles, G
    Banchereau, J
    Garrone, P
    BLOOD, 1996, 88 (10) : 1174 - 1174
  • [6] Resistance to Fas-induced apoptosis in CD40-activated B-CHRONIC lymphocytic leukemia cells.
    NeidhardtBerard, EM
    Garcia, E
    Durand, I
    Coiffier, B
    Salles, G
    Banchereau, J
    Garrone, P
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 73 - 73
  • [7] Human interdigitating dendritic cells directly stimulate CD40-activated naive B cells
    Bjorck, P
    FloresRomo, L
    Liu, YJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1266 - 1274
  • [8] Cytokine profile of CD40-activated B-CLL: Opportunities to refine cellular vaccines in B cell malignancies.
    Schultze, JL
    Maecker, B
    von Bergwelt-Baildon, M
    Gribben, JG
    Nadler, LM
    BLOOD, 1999, 94 (10) : 634A - 634A
  • [9] In vivo assessment of CD40-activated B cells as cellular adjuvant for immunotherapy of cancer
    Liebig, T. M.
    Shimabukuro-Vornhagen, A.
    Tawadros, S. -G
    Klein-Gonzalez, N.
    Draube, A.
    von Bergwelt-Baildon, M. S.
    ONKOLOGIE, 2011, 34 : 170 - 170
  • [10] CD40-activated B cells induce anti-tumor immunity in vivo
    Wennhold, Kerstin
    Weber, Tanja M.
    Klein-Gonzalez, Nela
    Thelen, Martin
    Garcia-Marquez, Maria
    Chakupurakal, Geothy
    Fiedler, Anne
    Schloesser, Hans A.
    Fischer, Rieke
    Theurich, Sebastian
    Shimabukuro-Vornhagen, Alexander
    von Bergwelt-Baildon, Michael
    ONCOTARGET, 2017, 8 (17) : 27740 - 27753
12345